Description
Letrozole AB (Norva-Access) 2.5mg Tablets (30’s) contain Letrozole, a potent aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. By inhibiting estrogen synthesis, it effectively slows or halts the progression of estrogen-dependent tumors.
Key Features:
-
Active Ingredient: Letrozole 2.5mg
-
Pack Size: 30 tablets
-
Indications: Treatment of hormone receptor-positive breast cancer; also used off-label for ovulation induction in infertility cases
-
Benefits: Reduces estrogen levels, helping to control tumor growth and improve fertility outcomes
-
Dosage: Oral administration as prescribed by a healthcare professional
-
Precautions: Not recommended for use during pregnancy or breastfeeding; requires medical supervision
Ensure to follow your healthcare provider’s instructions and complete the full course of therapy for optimal results.
Reviews
There are no reviews yet.